Purolite Selects Repligen’s Market-Leading OPUS® Pre-Packed Columns

Purolite Life Sciences, a leading provider of agarose chromatography resins, has announced its collaboration with Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership and the maker of the market-leading OPUS® line of pre-packed chromatography columns. The Company has selected Repligen’s OPUS® technology to provide Purolite customers with a premier end-to-end solution for the downstream purification of biologic drugs, specifically monoclonal antibody-based biologics. Under the terms of the agreement, Purolite will promote the full range of Repligen’s GMP-ready OPUS® pre-packed columns to customers seeking a flexible disposable alternative to self-packed glass columns. The agreement pairs Purolite’s high-flow Praesto® Protein A affinity and ion exchange agarose resins with the OPUS® portfolio of chromatography columns for bench-through production-scale purification needs.

Chris Major, Sales Director at Purolite, said “This collaboration supports our strategy to provide greater choice and flexibility to customers running downstream processes. We selected OPUS® columns for their market leadership along with technology and scale advantages, and the level of customization that Repligen delivers. OPUS® columns are ready-to-use, pre-packed alternatives to self-packing in-house, and have the broadest range of diameters available on the market, as well as flexible bed heights. This attention to customer needs aligns nicely with our Praesto® portfolio of agarose-based, high-flow chromatography resins that have demonstrated superior performance to current available alternatives in terms of capacity, lifetime and overall cost of goods.” He continued by saying “Our customers will benefit from this collaboration between two trusted suppliers who, with over 70 years of combined expertise and innovation, are enabling downstream solutions to be delivered quicker, faster and more efficiently than ever before.”

Steve Tingley, Repligen’s Vice President of Sales, added “Over the last 5 years, pre-packed column technology has become mainstream for many biological drug manufacturers seeking to improve facility flexibility, speed-to-market and overall process economics. Many of these companies have adopted Repligen’s OPUS® technology as a standard platform solution for their pre-packed chromatography column needs. This type of collaboration with chromatography resin suppliers greatly simplifies pre-packed column sourcing for customers. Specifically, this agreement with Purolite will ensure short delivery lead times for customers who opt for Purolite’s Praesto® agarose-based resins with pre-packed OPUS® column convenience.”

Ends

Notes to editors

About Purolite Life Sciences

Since 1981, Purolite has been a trusted supplier of resin to the world’s most regulated industries. Through innovative R&D, Purolite Life Sciences has met the needs of tomorrow before they arrive. Today we offer a range of bioprocess scale high flow agarose resins for the purification of monoclonal antibodies and recombinant proteins. Our success is rooted in the quality and consistency of our products, working hand in hand with customers. With over 35 years of resin knowledge combined with our customer-focused approach and global manufacturing capacity, Purolite Life Sciences is committed to:

• Security of supply for agarose resins
• Regulatory and Quality
• Innovation – Jetted uniform particle size agarose

www.purolitelifesciences.com

Follow us on Twitter: @PuroliteLifeSci
Follow us on LinkedIn: Purolite Life Sciences

Media Contact:

Purolite Life Sciences
N: Marc Davies
E: marc.davies@purolite.com
T: (+44)1443 229334

More within